equityflowunderstand the flow and follow it
EquityFlow › Companies › EnginZyme

EnginZyme

Biotech · Stockholm, SE

Cell-free biomanufacturing platform for sustainable chemical production.

In the network

Shares the most investors with (number = shared investors):
AlixLabs 2Arevo 2Peafowl Plasmonics 2Pixelgen Technologies 2Retein 2

Funding history

DateRoundAmount
Dec 2022Series B
Stockholm-based biomanufacturing company EnginZyme raised a EUR21M Series B from new backers Almi Invest GreenTech, Navigare Ventures and Bunge Ventures, with Sofinnova Partners, Industrifonden and SEB GreenTech VC returning.
$22.7M

Investors

Tap an investor to see what else they have backed.

Almi Invest GreenTechBunge VenturesIndustrifondenNavigare VenturesSEB GreenTech VCSofinnova Partners

Other companies in Biotech

ImperagenHaga BiosciencePixelgen TechnologiesGallantChai DiscoverySNIPR BiomeCellbox LabsScope BiosciencesGenLuminaActitheraNUCLIDIUMAnocca

Other companies in SE

Haga BioscienceGridlyOplanePixelgen TechnologiesTandem HealthLovableNordic Air DefenceEngrateEcohelixFind My FactoryStudio555Techarena

Other companies at Series B stage

0x Labs11x.ai1K Kirana1X Technologies1plusX3Commas3SC4baseCare4screen8fig9finACALL
Explore funding flow on EquityFlow →

Data is community-curated and may be incomplete.